User:BusterTheBusta/4-Hydroxytryptamine

4-Hydroxytryptamine
Stick model of 4-Hydroxytryptamine
Clinical data
Other names4-Hydroxytryptamine; 3-(2-Aminoethyl)-1H-indol-4-ol; UNII-DP0D1701D1
Routes of
administration
Oral, Intravenous
Pharmacokinetic data
MetabolismMAO, others
Metabolites4-HIAA
Excretionurine, feces
Identifiers
  • 3-(2-aminoethyl)-1H-indol-4-ol
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC10H12N2O
Molar mass176.219 g·mol−1
3D model (JSmol)
  • C1=CC2=C(C(=C1)O)C(=CN2)CCN
  • InChI=1S/C10H12N2O/c11-5-4-7-6-12-8-2-1-3-9(13)10(7)8/h1-3,6,12-13H,4-5,11H2
  • Key:FKIRTWDHOWAQGX-UHFFFAOYSA-N
4-Hydroxytryptamine
Names
IUPAC name
3-(2-aminoethyl)-1H-indol-4-ol
Other names
4-Hydroxytryptamine; 3-(2-Aminoethyl)-1H-indol-4-ol; UNII-DP0D1701D1
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
KEGG
  • InChI=1S/C10H12N2O/c11-5-4-7-6-12-8-2-1-3-9(13)10(7)8/h1-3,6,12-13H,4-5,11H2
    Key: FKIRTWDHOWAQGX-UHFFFAOYSA-N
  • C1=CC2=C(C(=C1)O)C(=CN2)CCN
Properties
C10H12N2O
Molar mass 176.218 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

4-Hydroxytryptamine or 4-HT is a monoamine of the tryptamine class. It occurs in psilocybin-mushrooms as a necessary chemical precursor for the biosythesis of psilocybin, psilocin, baeocystin, norbaeocystin and aeruginascin[1]. It is converted into these different compounds through a range of enzymes in psilocybin mushrooms, such as 4-hydroxytryptamine kinase found in psilocybe cubensis[1]. It is a structural analog as well an isomer of serotonin, differening by the hydroxy-group being on the 4th position on the tryptamine structure, instead of the 5th.

Possible effects

edit

These Effects are based on a small study from 1960 using one „intact“ cat, one „spinal“ cat, one dog and a rat[2]

  • Blood pressure: Cat, 4-HT (100µg/kg i.v.) produced a rise in blood pressure 2-6 times less intense but more sustained than the same dose of 5-HT.
  • Respiration: Dog, 3-4µg/kg i.v. of 5-HT caused a transitory stimulation of respiration, eventually followed by hypopnea. 4-HT required a higher dosage than 5-HT and result was always respiratory depression. Cat, both 5-HT and 4-HT caused bronchospasm. Effects of 4-HT at 100µg/kg i.v. were 2-4 times less intense but lasted longer than that caused by 5-HT.
  • Dog urinary bladder: Stimulant action of 4-HT was approximately 2 times less intense than that of 5-HT, but was more sustained.
  • Diuresis of hydrated rats: subcutaneous 4-HT showed only a poor antidiuretic effect. 6mg/kg were less effective than 0.04mg/kg 5-HT1.
  • Nictitating membrane: 4-HT was 2-5 times less active than 5-HT in contracting the nictitating membrane of the cat. The contraction by 4-HT lasted considerably longer.
Receptor Binding in Ki[3]
Receptor Rat Human
5-HTR1a 0.095µM -
5-HTR1b 1.05µM -
5-HTR2a 0.725µM -
5-HTR2b 0.725µM -
5-HTR2c 0.725µM 0.04µM

Metabolism

edit

After rats were given 4-HTP, a number of metabolites were found in their urine such as 4-HT as 4-HIAA[4].

Doses of 200mg, 500mg, 1000mg DL-4-HTP produce no pharmacological effects in man[4]. 4-HIAA was the most abundant metabolite in the urine at 95-100mg after the 1000mg Dose, 53-55mg after 500mg and 22-24mg after 200mg. Only 1.3-2.2% of the administered amino acid was recovered aunchanged in the urine and less than 1% 4-HT[4].

Peaks were reached after 2 Hours at all Doses.

These results suggest that oral 4-HTP and the 4-HT originating from it are extensively metabolized by the intestinal wall and in the liver.


  1. ^ a b PubChem. "2.-.-.- Transferases | 2.7.-.- Transferring phosphorus-containing groups | 2.7.1.- Phosphotransferases with an alcohol group as acceptor". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-05-10.
  2. ^ Erspamer, V.; Glässer, A.; Mantegazzini, P. (1960-11-01). "Pharmacological actions of 4-hydroxytryptamine and 4-hydroxytryptophan". Experientia. 16 (11): 505–506. doi:10.1007/BF02158367. ISSN 1420-9071.
  3. ^ PubChem. "4-Hydroxytryptamine". pubchem.ncbi.nlm.nih.gov. Retrieved 2022-05-10.
  4. ^ a b c Erspamer, V.; Nobili, M. B. (1961-08-01). "Observations on the fate of oral 4-hydroxytryptophan in man". Experientia. 17 (8): 351–352. doi:10.1007/BF02201756. ISSN 1420-9071.